病毒感染Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2.
期刊:Nature communications发表年份:2021作者:Hanjun Zhao; Kelvin K W To; Hoiyan Lam; Xinxin Zhou; Jasper Fuk-Woo Chan; Zheng Peng; Andrew C Y Lee; Jianpiao Cai; Wan-Mui Chan; Jonathan Daniel Ip; Chris Chung-Sing Chan; Man Lung Yeung; Anna Jinxia Zhang; Allen Wing Ho Chu; Shibo Jiang; Kwok-Yung
